Literature DB >> 62802

Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay.

V Knez, J A Stewart, D W Ziegler.   

Abstract

An indirect solid phase micro-radioimmunoassay (RIA) was adapted for the measurement of anti-cytomegalovirus class-specific immunoglobulin M (IgM) and immunoglobulin G (IgG). Cytomegalovirus (CMV) antigen (Ag) was added to the wells of microtiter plates and desiccated onto the bottom surface of the wells. Serial dilution of human CMV antisera were added and allowed to react with the Ag. The amount of viral antibody (Ab) was determined by measuring the specific binding of 125I-labeled goat anti-human IgG (125I-AHIgG) and/or IgM (125I-AHIgM). The multiple factors which influence the test were determined. Serial samples of sera from CMV-positive patients showed progressive increases in Ab titers on the basis of specific binding of 125I-AHIgG. The titers of IgM class anti-CMV Ab were also determined with the same sera, and enhancement of the titers was demonstrated when the incubation periods of the first Ag-Ab reaction were extended from 1 to 3 hr. The competition between the different Ig classes of Ab for CMV Ag and the involvement of rheumatoid factor (RF) were investigated. The anti-CMV IgG that may compete with the IgM determination was removed by adsorption of sera with Staphylococcus aureus (Cowan 1). The RF that would cause false anti-CMV IgM results was adsorbed with glutaraldehyde-insolubilized IgG. Our results indicate that this RIA is a practical, specific, and reproducible technique for detection of specific IgG and IgM Ab to CMV.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62802

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections.

Authors:  H Wulff; K M Johnson
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T A Aziz; H Stern
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

3.  Elimination of false-positive cytomegalovirus immunoglobulin M-fluorescent-antibody reactions with immunoglobulin M serum fractions.

Authors:  P W Robertson; V Kertesz; M J Cloonan
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

4.  Detection of specific immunoglobulin M antibodies to cytomegalovirus by using monoclonal antibody to immunoglobulin M in an indirect immunofluorescence assay.

Authors:  M Zerbini; M Musiani; G Gentilomi; M La Placa
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

5.  Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.

Authors:  M G Friedman; S Leventon-Kriss; I Sarov
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

6.  Neonatal chlamydial conjunctivitis.

Authors:  K Persson; R Rönnerstam; L Svanberg; S Polberger
Journal:  Arch Dis Child       Date:  1986-06       Impact factor: 3.791

7.  Enzyme immunoassays for measurement of cytomegalovirus immunoglobulin M antibody.

Authors:  R H Yolken; F J Leister
Journal:  J Clin Microbiol       Date:  1981-10       Impact factor: 5.948

8.  The detection of rubella-specific IgM antibodies by radioimmunoassay.

Authors:  H O Kangro; J R Pattison; R B Heath
Journal:  Br J Exp Pathol       Date:  1978-12

9.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

10.  Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus.

Authors:  R V Krishna; O H Meurman; T Ziegler; U H Krech
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.